申请人:Bäschlin Daniel Kaspar
公开号:US20130012485A1
公开(公告)日:2013-01-10
Compounds of the formula (I) are provided:
wherein V, W, X, Y, Z, R
3
, R
4
, R
5
, R
6
, R
7
and m are as defined in the specification; and pharmaceutically acceptable salts and prodrugs thereof. The compounds may be useful in the treatment or prevention of various diseases and conditions in which dipeptidylpeptidase-IV (DPP-IV) is implicated.
提供了化学式(I)的化合物:
其中V、W、X、Y、Z、R3、R4、R5、R6、R7和m的定义如规范中所述;以及其药学上可接受的盐和前药。这些化合物可能在治疗或预防各种与二肽基肽酶-IV(DPP-IV)有关的疾病和病况中有用。